| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
🧠 Neurological anatomy, physiology and pharmacology — neurology is about where the problem is before what it is. Knowing the lobes, the cranial nerves, the blood supply, the spinal tracts, the roots and the peripheral nerves lets you localise a lesion from the history and examination. Most neurological drugs work by changing ion channels, neurotransmitters or the immune system.
Your four questions for every drug: How does it work? What is it used for? What are the important side effects and safety issues? What does it interact with, and how is it monitored?
| Lobe | Main functions | Signs of damage |
|---|---|---|
| Frontal | Movement (motor cortex — precentral gyrus), planning, personality, behaviour, judgement; Broca's area (speech output, dominant side); eye movements (frontal eye fields); bladder control | Contralateral weakness; personality change, disinhibition, apathy; expressive (Broca's) dysphasia — slow, effortful speech with good understanding; primitive reflexes; urinary incontinence; eyes deviate towards the lesion (destructive) or away (seizure) |
| Parietal | Sensation (sensory cortex — postcentral gyrus), spatial awareness, calculation | Contralateral sensory loss (cortical — loss of two-point discrimination, astereognosis); dominant — Gerstmann's syndrome (acalculia, agraphia, finger agnosia, left–right confusion); non-dominant — neglect, dressing apraxia; contralateral inferior quadrantanopia |
| Temporal | Hearing, memory (hippocampus), language understanding (Wernicke's area, dominant side), emotion, smell and taste | Receptive (Wernicke's) dysphasia — fluent but meaningless speech, poor understanding; memory loss; contralateral superior quadrantanopia ("pie in the sky"); seizures with déjà vu, smell, rising stomach feeling |
| Occipital | Vision | Contralateral homonymous hemianopia (often with macular sparing); cortical blindness if both sides |
| Nerve | Main functions | Key clinical points |
|---|---|---|
| I Olfactory | Smell | Lost after head injury, with viral infections (including COVID-19), early in Parkinson's |
| II Optic | Vision; afferent pupil reflex | Acuity, colour, fields, fundi; relative afferent pupillary defect in optic neuritis |
| III Oculomotor | Most eye movements, lifts eyelid, constricts pupil | "Down and out" eye, ptosis; dilated pupil = compression (posterior communicating artery aneurysm, uncal herniation — pupil fibres run on the outside); pupil-sparing = medical (diabetes, hypertension) |
| IV Trochlear | Superior oblique — looks down and in | Vertical double vision, worse going downstairs; head tilted away from the affected side |
| V Trigeminal | Facial sensation (V1, V2, V3), chewing muscles; corneal reflex (sensory) | Trigeminal neuralgia; loss of corneal reflex is an early sign of a cerebellopontine angle tumour; shingles of V1 (Hutchinson's sign — tip of nose → eye involvement) |
| VI Abducens | Lateral rectus — looks out | Horizontal double vision; a "false localising sign" of raised intracranial pressure |
| VII Facial | Facial expression; taste (front two-thirds of tongue); tears, saliva; stapedius | Lower motor neurone (Bell's palsy) — whole face, including forehead; upper motor neurone (stroke) — forehead spared (bilateral cortical supply) |
| VIII Vestibulocochlear | Hearing and balance | Sensorineural deafness, vertigo; vestibular schwannoma (one-sided deafness — MRI); aminoglycoside toxicity |
| IX Glossopharyngeal | Taste (back third of tongue), sensation of the pharynx (gag reflex sensory), carotid sinus | Usually affected with X (bulbar palsy) |
| X Vagus | Palate, pharynx and larynx muscles; parasympathetic to the heart and gut | Uvula deviates away from the weak side; hoarseness (recurrent laryngeal branch) |
| XI Accessory | Sternocleidomastoid and trapezius | Weak shoulder shrug and head turning; injured in neck surgery |
| XII Hypoglossal | Tongue movement | Tongue deviates towards the weak side; wasting and fasciculations in motor neurone disease |
| Artery | Supplies | Stroke signs |
|---|---|---|
| Anterior cerebral | Medial frontal and parietal lobes | Contralateral leg weakness more than arm; behaviour change, incontinence |
| Middle cerebral | Lateral hemisphere, internal capsule | Contralateral face and arm weakness more than leg, sensory loss, homonymous hemianopia; dysphasia (dominant) or neglect (non-dominant) |
| Posterior cerebral | Occipital lobe, thalamus | Contralateral homonymous hemianopia with macular sparing; visual agnosia |
| Lenticulostriate (small penetrating arteries) | Internal capsule, basal ganglia, thalamus | Lacunar syndromes — pure motor, pure sensory, ataxic hemiparesis; no cortical signs |
| Vertebrobasilar | Brainstem, cerebellum, occipital lobes | Vertigo, ataxia, double vision, dysarthria, crossed signs, hemianopia; basilar occlusion — coma or "locked-in" syndrome |
| PICA (posterior inferior cerebellar) | Lateral medulla, cerebellum | Lateral medullary syndrome |
| Tract | Carries | Where it crosses |
|---|---|---|
| Corticospinal (pyramidal) | Voluntary movement | Crosses in the lower medulla (pyramidal decussation) — runs down on the same side as the muscles it controls |
| Dorsal columns | Vibration, joint position sense, fine touch | Runs up on the same side and crosses in the medulla |
| Spinothalamic | Pain and temperature (and crude touch) | Crosses within 1–2 segments of entering the cord — runs up on the opposite side |
| Spinocerebellar | Unconscious position sense to the cerebellum | Mostly uncrossed |
| Root | Dermatome (sensation) | Myotome (movement) | Reflex |
|---|---|---|---|
| C5 | Lateral upper arm | Shoulder abduction, elbow flexion | Biceps (C5–C6) |
| C6 | Lateral forearm and thumb | Wrist extension, elbow flexion | Supinator (brachioradialis — C5–C6) |
| C7 | Middle finger | Elbow, wrist and finger extension | Triceps (C7) |
| C8 | Little finger, medial forearm | Finger flexion (grip) | Finger jerk |
| T1 | Medial upper arm | Finger abduction (small hand muscles) | — |
| T4 / T10 | Nipple / umbilicus | Trunk muscles | Abdominal reflexes |
| L1–L2 | Groin, upper thigh | Hip flexion | Cremasteric (L1) |
| L3–L4 | Front of thigh, medial knee and shin (L4) | Knee extension, ankle dorsiflexion (L4) | Knee (L3–L4) |
| L5 | Lateral shin, top of foot and big toe | Big toe extension, ankle dorsiflexion and inversion, hip abduction | None reliable |
| S1 | Lateral foot, sole, little toe | Plantarflexion (tiptoe), eversion | Ankle (S1–S2) |
| S2–S4 | Perianal ("saddle") area | Bladder, bowel, anal sphincter | Anal reflex |
| Nerve | Common site of damage | Features |
|---|---|---|
| Median | Wrist (carpal tunnel) | Numbness of the thumb, index, middle and half the ring finger, worse at night; weak thumb abduction; thenar wasting. Risk factors — pregnancy, hypothyroidism, diabetes, acromegaly, RA, dialysis, obesity |
| Ulnar | Elbow (cubital tunnel) or wrist | Numbness of the little finger and half the ring finger; weak finger spreading; wasting of the small hand muscles (first dorsal interosseous), claw hand; Froment's sign |
| Radial | Spiral groove of the humerus ("Saturday night palsy"), shaft fractures | Wrist drop; numbness over the back of the thumb web space; triceps spared if the lesion is low |
| Axillary | Shoulder dislocation, humeral neck fracture | Weak shoulder abduction (deltoid); numbness over the "regimental badge" area |
| Long thoracic | Surgery (mastectomy), carrying heavy loads | Winged scapula (serratus anterior) |
| Common peroneal (fibular) | Fibular head — leg crossing, plaster casts, weight loss, prolonged squatting, knee surgery | Foot drop; weak eversion; inversion preserved; numbness of the top of the foot |
| Lateral cutaneous nerve of the thigh | Under the inguinal ligament | Meralgia paraesthetica — burning numbness of the outer thigh (obesity, tight belts, pregnancy) |
| Sciatic | Hip surgery, IM injections in the wrong spot, pelvic fractures | Weakness below the knee, foot drop; numbness below the knee except the medial side |
| Feature | Sympathetic | Parasympathetic |
|---|---|---|
| Origin | Thoracolumbar cord (T1–L2) | Cranial nerves III, VII, IX, X and sacral S2–S4 |
| Ganglia | Near the cord (sympathetic chain) | Near or in the target organ |
| Transmitter at the target | Noradrenaline (except sweat glands — acetylcholine) | Acetylcholine (muscarinic receptors) |
| Effects | Fast heart rate, dilated pupils, bronchodilatation, sweating, slow gut, vasoconstriction, bladder relaxation, ejaculation | Slow heart rate, small pupils, saliva and tears, gut movement, bladder emptying, erection |
| Transmitter | Role | Clinical and drug links |
|---|---|---|
| Glutamate | Main excitatory transmitter; learning and memory (NMDA and AMPA receptors) | Excitotoxic cell death in stroke and trauma; memantine and ketamine block NMDA; perampanel blocks AMPA; riluzole reduces release (MND) |
| GABA | Main inhibitory transmitter in the brain | Benzodiazepines, barbiturates, Z-drugs, propofol, alcohol enhance GABA-A; baclofen acts on GABA-B; valproate and vigabatrin raise GABA; withdrawal of these → seizures |
| Glycine | Inhibitory in the spinal cord and brainstem | Tetanus toxin and strychnine block it → spasms |
| Acetylcholine | Neuromuscular junction (nicotinic), autonomic nerves, memory and attention (brain) | Loss in Alzheimer's (donepezil); myasthenia gravis; anticholinergic drugs cause confusion |
| Dopamine | Four pathways: movement (nigrostriatal), reward (mesolimbic), thinking (mesocortical), prolactin control (tuberoinfundibular); also triggers nausea (CTZ) | Parkinson's (loss); antipsychotics block it (parkinsonism, raised prolactin); dopamine drugs cause nausea, hallucinations and impulse control problems |
| Noradrenaline | Arousal, attention, mood, pain modulation | SNRIs (duloxetine) and TCAs for neuropathic pain and depression |
| Serotonin (5-HT) | Mood, sleep, appetite, pain, nausea, blood vessel tone | Triptans (5-HT1B/1D agonists) in migraine; ondansetron (5-HT3); SSRIs; serotonin syndrome |
| Histamine | Wakefulness, vestibular signals | Sedating antihistamines (cyclizine, promethazine); pitolisant (narcolepsy) |
| Endorphins and enkephalins | Natural pain relief | Opioid drugs act on the same receptors |
| CGRP and substance P | Pain signalling and blood vessel dilatation | CGRP antibodies and gepants in migraine; capsaicin depletes substance P |
| Orexin (hypocretin) | Keeps us awake | Loss in narcolepsy with cataplexy |
| Sign | Upper motor neurone (brain, cord) | Lower motor neurone (anterior horn, root, nerve) |
|---|---|---|
| Tone | Increased (spastic — "clasp-knife") | Reduced (flaccid) |
| Weakness pattern | "Pyramidal" — arm extensors and leg flexors weakest | In the distribution of the root or nerve |
| Wasting | Little (disuse only) | Marked |
| Fasciculations | No | Yes (especially motor neurone disease) |
| Reflexes | Brisk, with clonus | Reduced or absent |
| Plantar response | Upgoing (Babinski) | Downgoing |
| Measure | Typical adult value |
|---|---|
| CSF opening pressure | About 10–20 cmH2O (lying on the side; up to about 25 in obesity) |
| CSF white cells | Under 5 cells/microlitre (lymphocytes) |
| CSF red cells | None (a few from a traumatic tap) |
| CSF protein | About 0.15–0.45 g/L |
| CSF glucose | About 60% or more of the blood glucose (take a paired blood glucose) |
| CSF volume / production | About 150 mL / about 500 mL a day |
| Intracranial pressure | About 5–15 mmHg |
| Cerebral perfusion pressure | Aim above about 60 mmHg in brain injury |
| Phenytoin level | About 10–20 mg/L (correct for low albumin) |
| Carbamazepine level | About 4–12 mg/L |
| Condition | Cells | Protein | Glucose |
|---|---|---|---|
| Bacterial meningitis | High — neutrophils | High | Low |
| Viral meningitis | Raised — lymphocytes | Normal or slightly raised | Normal |
| TB meningitis | Raised — lymphocytes | Very high | Low |
| Fungal (cryptococcal) | Raised — lymphocytes | High | Low; very high opening pressure; cryptococcal antigen |
| Guillain–Barré | Normal | High (albuminocytological dissociation) | Normal |
| Multiple sclerosis | Normal or slightly raised | Normal or slightly raised | Normal; oligoclonal bands in CSF but not blood |
| Subarachnoid haemorrhage | Many red cells | Raised | Normal; xanthochromia (LP at least 12 hours after onset) |
⚠️ Safety Pearl: Count every benzodiazepine dose given before arrival (buccal midazolam by family or paramedics counts). Two doses total, then move to a second-line drug — more benzodiazepines mostly add respiratory depression.
⚠️ Safety Pearl: Parkinson's drugs are time-critical — give them within 30 minutes of the patient's usual time. Never stop them suddenly (rigidity, inability to swallow, aspiration and a neuroleptic malignant-like syndrome). If nil by mouth, use an NG tube or a rotigotine patch (use a dose conversion calculator and get specialist advice).
| Drug | Type | Key risks |
|---|---|---|
| Interferon beta, glatiramer acetate | Injectable, moderate efficacy | Flu-like symptoms, injection site reactions, low mood, LFTs (interferon); safe-ish in pregnancy planning |
| Dimethyl fumarate, diroximel fumarate | Oral | Flushing, GI upset, lymphopenia (rare PML) — FBC monitoring |
| Teriflunomide | Oral | Hair thinning, liver toxicity, teratogenic (accelerated elimination needed before pregnancy) |
| Fingolimod, siponimod, ozanimod, ponesimod | Oral S1P modulators | Bradycardia with the first dose (monitoring), macular oedema, shingles (check varicella immunity), skin cancer, rebound on stopping; teratogenic |
| Cladribine | Oral, short courses | Lymphopenia, infections (shingles), teratogenic |
| Ocrelizumab, ofatumumab, ublituximab | Anti-CD20 antibodies (B-cell depletion) | Infusion or injection reactions, infections, hepatitis B reactivation (screen), low immunoglobulins; ocrelizumab also for early primary progressive MS |
| Natalizumab | Infusion (blocks immune cells entering the brain) | PML (brain infection by JC virus) — test for JC virus antibodies and monitor with MRI |
| Alemtuzumab | Infusion (anti-CD52) | Secondary autoimmune disease (thyroid, ITP, kidney) — monthly blood and urine monitoring for years; stroke and infusion reactions |
| Problem | Typical drugs |
|---|---|
| Seizures (lower threshold) | Tramadol, bupropion, theophylline, ciprofloxacin and other quinolones, high-dose penicillins and carbapenems, clozapine and other antipsychotics, TCAs, lithium toxicity, isoniazid (pyridoxine), local anaesthetic toxicity, withdrawal of alcohol, benzodiazepines, baclofen or antiseizure drugs; drugs causing low sodium or glucose |
| Delirium and confusion | Anticholinergics, opioids, benzodiazepines, gabapentinoids, steroids, Parkinson's drugs, digoxin, lithium, antihistamines, H2 blockers, quinolones |
| Parkinsonism and other movement disorders | Antipsychotics, metoclopramide, prochlorperazine, valproate (tremor, parkinsonism), lithium (tremor), SSRIs; acute dystonia (metoclopramide, haloperidol); tardive dyskinesia (long-term dopamine blockers) |
| Serotonin syndrome | SSRIs and SNRIs with tramadol, MAOIs, linezolid, triptans (rare), St John's wort, fentanyl, MDMA |
| Neuroleptic malignant syndrome | Antipsychotics, metoclopramide; stopping levodopa or dopamine agonists |
| Peripheral neuropathy | Isoniazid, metronidazole (long courses), nitrofurantoin, vincristine, platinum drugs (cisplatin, oxaliplatin), taxanes, bortezomib, amiodarone, phenytoin, linezolid, dapsone, colchicine, some HIV drugs, nitrous oxide (B12), alcohol |
| Myopathy | Statins (especially with fibrates, macrolides, ciclosporin), steroids, colchicine, zidovudine, alcohol, immune checkpoint inhibitors (also myositis and myasthenia) |
| Raised intracranial pressure (IIH) | Tetracyclines (doxycycline, minocycline), isotretinoin and vitamin A, steroid withdrawal, lithium, growth hormone |
| Ototoxicity | Aminoglycosides, cisplatin, high-dose IV loop diuretics, high-dose aspirin, quinine |
| Cerebellar ataxia | Phenytoin, carbamazepine, lithium, alcohol, metronidazole (encephalopathy), chemotherapy (cytarabine, 5-FU) |
| Headache | Nitrates, calcium channel blockers, PDE5 inhibitors, medication overuse (painkillers, triptans, opioids), caffeine withdrawal |
| Optic nerve damage | Ethambutol, amiodarone, linezolid, PDE5 inhibitors and semaglutide (ischaemic optic neuropathy — rare) |
| PML (JC virus brain infection) | Natalizumab, rituximab, dimethyl fumarate, other strong immunosuppressants |
| Posterior reversible encephalopathy (PRES) | Ciclosporin, tacrolimus, chemotherapy, severe hypertension, eclampsia |
| Worsening myasthenia | Aminoglycosides, quinolones, macrolides, magnesium, beta-blockers, checkpoint inhibitors |
| Bleeding into the brain | Anticoagulants, antiplatelets, thrombolytics, SSRIs (small extra risk with anticoagulants) |
| Drug | Key points |
|---|---|
| Sodium valproate | Broad spectrum; highly teratogenic — MHRA rules (not started under 55 without two specialists); weight gain, tremor, liver, pancreatitis, ammonia; raises lamotrigine; carbapenems lower it. |
| Lamotrigine | Slow titration — SJS rash (worse with valproate); oestrogen lowers levels; relatively safe in pregnancy. |
| Levetiracetam | Few interactions; renal dosing; mood and behaviour change; IV in status. |
| Carbamazepine | Trigeminal neuralgia; hyponatraemia; HLA-B*1502 testing; enzyme inducer (contraception); autoinduction. |
| Phenytoin | Zero-order kinetics; level 10–20 mg/L; nystagmus and ataxia in toxicity; gum overgrowth; IV max 50 mg/min with ECG. |
| Topiramate | Epilepsy and migraine; teratogenic (PPP); kidney stones, glaucoma, cognitive slowing. |
| Lorazepam / buccal midazolam | First-line in status; maximum two benzodiazepine doses. |
| Co-careldopa / co-beneldopa | Levodopa with decarboxylase inhibitor; time-critical; dyskinesias, wearing off, hallucinations, postural hypotension. |
| Ropinirole / pramipexole / rotigotine | Dopamine agonists; impulse control disorders, sudden sleep; rotigotine patch if nil by mouth. |
| Rasagiline / entacapone / amantadine | MAO-B inhibitor / COMT inhibitor (orange urine) / anti-dyskinesia. |
| Sumatriptan | 5-HT1B/1D agonist; avoid in IHD, stroke, PVD; SC 6 mg for cluster headache. |
| CGRP antibodies / gepants | Migraine prevention after 3 failed preventives; rimegepant also acute. |
| Propranolol / amitriptyline | Migraine prevention; propranolol also for essential tremor. |
| Verapamil | Cluster headache prevention — ECG for heart block. |
| Alteplase / tenecteplase | Thrombolysis within 4.5 hours; haemorrhage; BP under 185/110; no antithrombotics for 24 hours. |
| Aspirin 300 mg then clopidogrel | Ischaemic stroke — 2 weeks aspirin, then clopidogrel long term; DAPT 21 days for high-risk TIA or minor stroke. |
| Nimodipine | SAH — 60 mg 4-hourly for 21 days; hypotension. |
| Methylprednisolone | MS relapse — shortens it; exclude infection. |
| Natalizumab / ocrelizumab / alemtuzumab | MS DMTs; PML (JC virus) / infections, hepatitis B / secondary autoimmunity. |
| Pyridostigmine | Myasthenia; cholinergic side effects; overdose — cholinergic crisis. |
| IV immunoglobulin | GBS, myasthenic crisis; monitor FVC. |
| Riluzole | MND; LFTs and FBC. |
| Donepezil / rivastigmine | Alzheimer's, Lewy body and Parkinson's dementia; bradycardia, syncope, GI effects. |
| Memantine | NMDA antagonist; moderate to severe Alzheimer's; renal dosing. |
| Gabapentin / pregabalin | Neuropathic pain; controlled drugs; respiratory depression with opioids; renal dosing. |
| Duloxetine | SNRI for neuropathic pain; nausea, hyponatraemia, serotonin syndrome. |
| Baclofen / tizanidine | Spasticity; baclofen — never stop suddenly; tizanidine — not with ciprofloxacin or fluvoxamine. |
| Dantrolene | Malignant hyperthermia; severe NMS. |
| Prednisolone (Bell's palsy, GCA) | Bell's within 72 hours; GCA — start immediately. |
| Aciclovir / ceftriaxone / dexamethasone | Encephalitis / meningitis (add amoxicillin for Listeria risk) / adjunct in bacterial meningitis. |
| Procyclidine | Acute dystonic reactions. |
| Clue | Answer |
|---|---|
| Fluent, meaningless speech with poor understanding | Wernicke's (receptive) dysphasia — dominant temporal lobe |
| Leg weakness more than arm with urinary incontinence after a stroke | Anterior cerebral artery territory |
| Ignores the left side of the body after a stroke | Right (non-dominant) parietal lobe — neglect |
| Facial weakness sparing the forehead | Upper motor neurone lesion (stroke) |
| Ptosis, "down and out" eye and a dilated pupil with headache | Compressive third nerve palsy — posterior communicating artery aneurysm |
| Ipsilateral Horner's and facial numbness with contralateral body pain loss | Lateral medullary syndrome (PICA or vertebral) |
| Lens-shaped bleed after a blow to the temple with a lucid interval | Extradural haematoma — middle meningeal artery |
| Wet, wobbly, wacky in an older man with big ventricles | Normal pressure hydrocephalus |
| Same-side weakness and vibration loss, opposite-side pain loss | Brown-Séquard syndrome |
| Absent ankle jerks with upgoing plantars after nitrous oxide use | Subacute combined degeneration (B12) |
| Saddle anaesthesia and urinary retention after back pain | Cauda equina syndrome — emergency MRI |
| Foot drop with preserved inversion after crossing legs | Common peroneal nerve palsy |
| Thenar wasting and night-time tingling in the thumb and fingers | Carpal tunnel syndrome (median nerve) |
| Painful Horner's syndrome with neck pain | Carotid artery dissection |
| Bitemporal hemianopia | Chiasmal compression (pituitary tumour) |
| CSF protein 2.1 g/L with normal cell count and ascending weakness | Guillain–Barré syndrome |
| Fatigable ptosis and double vision worse in the evening | Myasthenia gravis |
| Weakness after gentamicin in a patient with ptosis | Aminoglycoside worsening myasthenia |
| Rash 3 weeks after valproate was added to lamotrigine | Lamotrigine SJS risk (valproate doubles levels) |
| Seizures return when a patient on valproate gets meropenem | Carbapenem interaction — valproate levels crash |
| Nystagmus, ataxia and slurred speech after a small phenytoin dose increase | Phenytoin toxicity (zero-order kinetics) |
| Sodium 122 in an older woman with trigeminal neuralgia | Carbamazepine hyponatraemia |
| Unplanned pregnancy in a woman on carbamazepine and the combined pill | Enzyme induction — contraceptive failure |
| New compulsive gambling in Parkinson's | Dopamine agonist impulse control disorder |
| Rigid, febrile Parkinson's patient who has been nil by mouth for 2 days | Parkinsonism-hyperpyrexia (missed levodopa) |
| Syncope and heart rate 42 in a patient on a dementia drug | Donepezil bradycardia |
1. A 32-year-old man with epilepsy is fitting in A&E. He has had buccal midazolam from his partner 10 minutes ago. The seizure has now lasted 15 minutes.
Answer: Convulsive status epilepticus.
2. A 24-year-old woman with newly diagnosed generalised tonic–clonic seizures asks to start sodium valproate, which worked well for her father.
Answer: Valproate should not be started — offer lamotrigine or levetiracetam.
3. A 78-year-old man with Parkinson's disease is nil by mouth after emergency bowel surgery. Two days later he is rigid, febrile, confused and his CK is 4,800.
Answer: Parkinsonism-hyperpyrexia syndrome from missed levodopa.
4. A 55-year-old woman with myasthenia gravis is given IV gentamicin for pyelonephritis. Next day she has slurred speech, difficulty swallowing and breathlessness. FVC is 1.2 L (normally 3 L).
Answer: Myasthenic crisis precipitated by an aminoglycoside (and infection).
5. An 80-year-old woman started on carbamazepine for trigeminal neuralgia is brought in confused. Sodium 119 mmol/L. She also takes bendroflumethiazide and warfarin; her INR has fallen to 1.4.
Answer: Carbamazepine-induced hyponatraemia (worsened by the thiazide) and enzyme induction lowering warfarin effect.